MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models

por Fingerle-Rowson, Günter, Petrenko, Oleksi
Publicado 2007

A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies

por Tobinai, Kensei, Klein, Christian, Oya, Naoko, Fingerle-Rowson, Günter
Publicado 2016

Brain Miffed by Macrophage Migration Inhibitory Factor

por Savaskan, Nic E., Fingerle-Rowson, Günter, Buchfelder, Michael, Eyüpoglu, Ilker Y.
Publicado 2012

Macrophage migration inhibitory factor promotes resistance to glucocorticoid treatment in EAE

por Ji, Niannian, Kovalovsky, Andra, Fingerle-Rowson, Günter, Guentzel, M. Neal, Forsthuber, Thomas G.
Publicado 2015

Pharmacokinetics, exposure, efficacy and safety of obinutuzumab in rituximab‐refractory follicular lymphoma patients in the GADOLIN phase III study

por Gibiansky, Ekaterina, Gibiansky, Leonid, Buchheit, Vincent, Frey, Nicolas, Brewster, Michael, Fingerle‐Rowson, Günter, Jamois, Candice
Publicado 2019

Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression

por Schulz, Ramona, Marchenko, Natalia D., Holembowski, Lena, Fingerle-Rowson, Günter, Pesic, Marina, Zender, Lars, Dobbelstein, Matthias, Moll, Ute M.
Publicado 2012

Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression

por Schulz, Ramona, Marchenko, Natalia D., Holembowski, Lena, Fingerle-Rowson, Günter, Pesic, Marina, Zender, Lars, Dobbelstein, Matthias, Mol, Ute M.
Publicado 2012

Macrophage migration inhibitory factor (MIF) and its homolog D-dopachrome tautomerase (D-DT) are significant promotors of UVB- but not chemically induced non-melanoma skin cancer

por Huth, Sebastian, Huth, Laura, Heise, Ruth, Marquardt, Yvonne, Lopopolo, Linda, Piecychna, Marta, Boor, Peter, Fingerle-Rowson, Günter, Kapurniotu, Aphrodite, Yazdi, Amir S., Bucala, Richard, Bernhagen, Jürgen, Baron, Jens Malte
Publicado 2023

The Outcome of Renal Ischemia-Reperfusion Injury Is Unchanged in AMPK-β1 Deficient Mice

por Mount, Peter F., Gleich, Kurt, Tam, Shanna, Fraser, Scott A., Choy, Suet-Wan, Dwyer, Karen M., Lu, Bo, Van Denderen, Bryce, Fingerle-Rowson, Günter, Bucala, Richard, Kemp, Bruce E., Power, David A.
Publicado 2012

Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first‐line immunochemotherapy

por Jamois, Candice, Gibiansky, Ekaterina, Gibiansky, Leonid, Buchheit, Vincent, Sahin, Denis, Cartron, Guillaume, Marcus, Robert, Hiddemann, Wolfgang, Seymour, John F., Strefford, Jonathan C., Hargreaves, Chantal E., Meneses‐Lorente, Georgina, Frey, Nicolas, Fingerle‐Rowson, Günter
Publicado 2019

Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study

por Bolen, Christopher R., Klanova, Magdalena, Trnény, Marek, Sehn, Laurie H., He, Jie, Tong, Jing, Paulson, Joseph N., Kim, Eugene, Vitolo, Umberto, Di Rocco, Alice, Fingerle-Rowson, Günter, Nielsen, Tina, Lenz, Georg, Oestergaard, Mikkel Z.
Publicado 2019

RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a Real-world Lenalidomide Monotherapy Cohort in Relapsed or Refractory Diffuse Large B-cell Lymphoma

por Zinzani, Pier Luigi, Rodgers, Thomas, Marino, Dario, Frezzato, Maurizio, Barbui, Anna Maria, Castellino, Claudia, Meli, Erika, Fowler, Nathan H., Salles, Gilles, Feinberg, Bruce, Kurukulasuriya, Nuwan C., Tillmanns, Sascha, Parche, Stephan, Dey, Debarshi, Fingerle-Rowson, Günter, Ambarkhane, Sumeet, Winderlich, Mark, Nowakowski, Grzegorz S.
Publicado 2021

Macrophage migration inhibitory factor promotes renal injury induced by ischemic reperfusion

por Li, Jin H, Tang, Ying, Lv, Jun, Wang, Xiao H., Yang, Hui, Tang, Patrick M. K., Huang, Xiao R., He, Zhi J., Zhou, Zi J, Huang, Qiu Y., Klug, Jörg, Meinhardt, Andreas, Fingerle‐Rowson, Günter, Xu, An P., Zheng, Zhi H., Lan, Hui Yao
Publicado 2019

Mural cell-derived chemokines provide a protective niche to safeguard vascular macrophages and limit chronic inflammation

por Pekayvaz, Kami, Gold, Christoph, Hoseinpour, Parandis, Engel, Anouk, Martinez-Navarro, Alejandro, Eivers, Luke, Coletti, Raffaele, Joppich, Markus, Dionísio, Flávio, Kaiser, Rainer, Tomas, Lukas, Janjic, Aleksandar, Knott, Maximilian, Mehari, Fitsumbirhan, Polewka, Vivien, Kirschner, Megan, Boda, Annegret, Nicolai, Leo, Schulz, Heiko, Titova, Anna, Kilani, Badr, Lorenz, Michael, Fingerle-Rowson, Günter, Bucala, Richard, Enard, Wolfgang, Zimmer, Ralf, Weber, Christian, Libby, Peter, Schulz, Christian, Massberg, Steffen, Stark, Konstantin
Publicado 2023